2022-2023 Symposium Series

Preparing health and human services professionals to address opioid use disorder

Headshot for Dr. Marianne Cloeren

Meet the Faculty Advisor

Marianne Cloeren, MD, MPH

Associate Professor, Div. of Occupational and Environmental Medicine

Pronouns: She/her/hers

 

Dr. Marianne is the Faculty Advisor for the 2022-2023 President’s Fellows and White Paper Project and an Associate Professor in the Division of Occupational and Environmental Medicine at the University of Maryland, School of Medicine. In 2018, Dr. Cloeren mobilized an interdisciplinary team of researchers, which received two grants in 2019 (the Institute for Clinical Translational Research (ICTR) Accelerated Translational Incubator Pilot (ATIP) grant and the Center for Addiction Research, Education and Services (CARES) Science to Systems grant) to study the work status and barriers to work in patients receiving Medication Assisted Treatment for Opioid Use Disorder in UMB clinical centers. Furthermore,  Dr. Cloeren joined forces with Dr. Jodi Jacobson Frey to study barriers to employment faced by adults in recovery from Opioid Use Disorders, focusing on how employers can support employees recovering from opioid addiction. Dr. Cloeren received her M.D. at Temple University School of Medicine, a B.A. in Biology and German from the University of Pennsylvania, and a Master of Public Health from Johns Hopkins School of Hygiene and Public Health. Additionally, Dr. Cloeren has a certificate in Instructional Design from the University of Wisconsin and is board certified in Internal Medicine and Occupational Medicine.

President's Symposium with Marianne Cloeren, MD, MPH

Why should the University of Maryland, Baltimore prepare students to address opioid use disorder?

The U.S. Department of Health and Human Services reports that since 1999, over 760,000 people have died from an opioid-related drug overdose (WONDER, 2022). The opioid epidemic, and lack of response, have been tied to systemic racism, social inequity, and poverty, where the individuals and communities experiencing the greatest impact have been simultaneously ignored and marginalized. For this, the opioid epidemic can be viewed as more than a public health crisis but also as a continued pillar of racial inequity and discrimination. With the addition of synthetic drugs such as fentanyl, cheaper alternatives have hit the market, further fueling the drug epidemic and simultaneously taking the lives of individuals struggling with addiction. Yet, as the opioid epidemic continues to accelerate, federal, state, and local governments attempt to mitigate the surge in opioid availability while developing innovative treatment methods and drug prevention efforts (Packard & Lee, 2021). As a health and human services institution, the University of Maryland, Baltimore should consider its continued role in the opioid epidemic by gaining a better understanding of the historic connection health care has had with opioid dependency and how an institution can improve patient care while addressing opioid use disorder.

References:

Packard, A. S., Lee, T. A. (2021). Combating the opioid epidemic in the United States. Drugs in Context, 10, 1–3. https://doi.org/10.7573/dic.2021-10-7

Wide-ranging online data for epidemiologic research (WONDER). (2022). National Center for Health Statistics. http://wonder.cdc.gov/